Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Memorial Sloan Kettering Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey S. Weber, MD, PhD

University of Southern California

Moderately Similar
9 trials

Shared therapeutic areas:

Melanoma (Skin)Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Ulka N. Vaishampayan, MD

Barbara Ann Karmanos Cancer Institute

Moderately Similar
6 trials

Shared therapeutic areas:

Uveal MelanomaMelanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

John R. Murren, MD

Yale University

Moderately Similar
6 trials

Shared therapeutic areas:

Uveal MelanomaMelanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Moderately Similar
29 trials

Shared therapeutic areas:

Melanoma (Skin)Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Paul Pharoah, MD

Cancer Research UK

Moderately Similar
7 trials

Shared therapeutic areas:

Uveal MelanomaMelanoma (Skin)
Similarity Score30%

Craig L. Slingluff, MD

University of Virginia

Moderately Similar
9 trials

Shared therapeutic areas:

Melanoma (Skin)Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Show-Li Sun, MD

Astex Pharmaceuticals, Inc.

Related
6 trials

Shared therapeutic areas:

Melanoma (Skin)
Similarity Score15%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Melanoma (Skin)
Similarity Score15%

Antoni Ribas, MD

Jonsson Comprehensive Cancer Center

Related
5 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Jeffrey A. Sosman, MD

Vanderbilt-Ingram Cancer Center

Related
6 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00085579Phase 2PrincipalInvestigator

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)
Withdrawn
NCT00104845Phase 1StudyChair

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Melanoma (Skin)
Completed
NCT00398073Phase 1PrincipalInvestigator

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Intraocular MelanomaMelanoma (Skin)
Completed

All 3 trials loaded